Shareholders Equity: The sum of preferred and common equity items.
TherapeuticsMD, Inc. (TXMD) had Shareholders Equity of $27.29M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$0.95M |
|
$0.55M |
|
-- |
|
$0.95M |
|
$1.65M |
|
$-0.69M |
|
$1.24M |
|
$0.55M |
|
$0.55M |
|
$0.55M |
|
$0.55M |
|
$0.55M |
|
$0.55M |
|
$-0.69M |
|
$-0.60M |
|
11.57M |
|
11.57M |
|
$0.05 |
|
$0.05 |
|
| Balance Sheet Financials | |
$13.46M |
|
-- |
|
$25.04M |
|
$38.50M |
|
$4.66M |
|
-- |
|
$6.55M |
|
$11.21M |
|
$27.29M |
|
$23.25M |
|
|
Shareholders Equity |
$27.29M |
11.57M |
|
| Cash Flow Statement Financials | |
$1.08M |
|
-- |
|
-- |
|
$5.06M |
|
$6.07M |
|
$1.01M |
|
$0.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.89 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-73.00% |
|
-73.00% |
|
-- |
|
57.25% |
|
57.88% |
|
$1.08M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
0.25 |
|
353.86 |
|
2.00% |
|
2.34% |
|
1.42% |
|
2.00% |
|
$2.36 |
|
$0.09 |
|
$0.09 |
|